Patients with acute coronary syndromes should received statins

Affiliations

¹ Department of Pediatric Cardiology, University of Michigan; The Cholesterol Treatment Center, Cincinnati, Ohio; Medical Research Laboratories, 2 Tesseneer, Highland Heights, KY 41076, USA.

Comment

Donald M Black et al. Curr Atheroscler Rep. 2002 Jan.

. 2002 Jan;4(1):11-3.

doi: 10.1007/s11883-002-0056-9.

¹ Department of Pediatric Cardiology, University of Michigan; The Cholesterol Treatment Center, Cincinnati, Ohio; Medical Research Laboratories, 2 Tesseneer, Highland Heights, KY 41076, USA.

No abstract available

Comment on

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A, Chaitman BR, Leslie S, Stern T; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Schwartz GG, et al. JAMA. 2001 Apr 4;285(13):1711-8. doi: 10.1001/jama.285.13.1711. JAMA. 2001. PMID: 11277825 Clinical Trial.